Eurasian Harm Reduction Association (EHRA) is a non-for-profit public membership-based organisation, registered by the initiative of harm reduction activists and organisations from Central and Eastern Europe and Central Asia (CEECA) in 2017.

We strive for a progressive human rights-based drug policy, sustainable funding advocacy and quality of harm reduction services oriented on needs of people who use drugs.


Baltics, Central Europe, South-Eastern Europe, European Countries of the Commonwealth of Independent States, Caucasus, Russia, Central Asia


Albania, Armenia, Azerbaijan, Belarus, Bosnia-Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Hungary, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan


Association is a membership based network. Nowadays the Association includes 214 members from CEECA region

Regional Сommunity Networks Consortium submitted multi-country proposal for GF funding to insure sustainability of HIV services for key populations in EECA
The Regional Community Networks Consortium (RCNC) of five regional networks in EECA has successfully developed and submitted a proposal for the Global Fund.
Read more.
EHRA is looking for for the expert to develop and facilitate Workshop in Azerbaijan
The Eurasian Harm Reduction Association (EHRA) in the scope of the EECA Regional Platform project supported by the Global Fund is aimed to organize a workshop targeted on civil society and community representatives in Azerbaijan. The workshop is going to take place in Baku (Azerbaijan) on 7 – 8 of
Read more.
Announcement of EHRA members online General Meeting
The Eurasian Harm Reduction Association (EHRA) announces the convocation of the members online General meeting, in period from 21st May 2018 to 4th June 2018. General meeting suggested agenda: 1. Approval of EHRA financial report for 2017 year (Statement from EHRA Treasurer will be sent until 16th May, 2018); 2. Approval
Read more.